We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MYOR:IDXPT Mayora Indah Tbk Analysis

Data as of 2026-09-01 - not real-time

IDR 1,565.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At IDR 1,565.00, PT Mayora Indah Tbk shows a bearish moving-average alignment, with shorter averages beneath longer ones. Over a rolling month the price has lost 10.6%. RSI sits at 33.0, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at IDR 1,530.00 up to resistance at IDR 1,730.00.
Valuation screens as undervalued, on a P/E of 10.2 with no clean sector comparison available. Consensus targets land 61.0% above where the shares trade now. Revenue is growing at 7.5% on a 8.8% profit margin. The 3.87% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 24.6%, a beta of 0.29 and a maximum drawdown of 37.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 5/10 conviction on the long call.

Top Market Events

KONTAN.CO.ID - Jakarta. Investor saham di Bursa Efek Indonesia BEI mulailah cek rekening dana investasi Anda. Hari ini,...KONTAN.CO.ID - JAKARTA. Emiten Fast Moving Consumer Goods FMCG , PT Mayora Indah Tbk MYOR masih mempertahankan...okezone ekonomi menyajikan kabar info berita saham valas investasi bursa efek IHSG terhangat nasional dan internasional...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1938.33
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1938.33
  • Analyst targets imply +61.0% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +61.0% versus the current price
  • P/E ratio of 10.2
  • Return on equity of 19.6%

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
Profit Margin8.78%
P/E Ratio10.2
ROE19.62%
ROA8.84%
Debt/Equity24.67
P/B Ratio1.9
Op. Cash FlowIDR6564.6B
Free Cash FlowIDR5363.2B

Technical Analysis

TrendBearish
RSI33.0
SupportIDR 1,530.00
ResistanceIDR 1,730.00
MA 20IDR 1,649.75
MA 50IDR 1,721.70
MA 200IDR 1,938.33
MACDBearish
VolumeIncreasing
Fear & Greed Index92.98

Valuation

Fair ValueIDR 4,307.97
Target PriceIDR 2,519.06
Upside/Downside60.96%
GradeUndervalued
TypeValue
Dividend Yield3.87%

Risk Assessment

Beta0.29
Volatility24.65%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.